How does cannabis private credit leverage differ from traditional private credit market approaches?
Answered at 2:48 in The Fast Five: Could cannabis private credit be an overlooked opportunity? · The Single Source
How does cannabis private credit leverage differ from traditional private credit market approaches?
Cannabis private credit funds target equity returns at two times leverage or less, whereas traditional private credit firms typically deploy five to ten times EBITDA while delivering only sub-10% yields. This conservative leverage structure fundamentally realigns risk and return incentives in the cannabis credit space.
The difference is not accidental—it reflects the structural realities of lending into limited-license cannabis markets. As Brendan Fay explains in the episode, cannabis operators in these restricted jurisdictions generate outsized profitability precisely because licenses are scarce. Deploying less leverage while targeting higher absolute returns per dollar deployed allows private credit firms to align with their borrowers' actual cash generation capacity rather than assume aggressive leverage can be serviced indefinitely.
The competitive environment reinforces this strategy. Lenders in cannabis private credit operate as price setters rather than price takers, a luxury unavailable to most traditional private credit firms drowning in capital competition. With approximately $5.4 billion in cannabis maturity obligations due in the next 24 months and a severe scarcity of available capital to refinance these loans, cannabis-focused lenders can dictate terms without racing to the bottom on pricing. Traditional private credit markets, by contrast, are saturated with capital seeking deployment, forcing firms to leverage higher just to compete on risk-adjusted returns.
This structural advantage extends beyond leverage ratios. By maintaining disciplined leverage discipline while targeting equity-like returns, cannabis private credit firms can weather volatility in both the macroeconomic environment and regulatory landscape. They avoid the trap of traditional private credit funds that have grown dependent on multiple compression to justify their outsized leverage—a trap that exposes them when markets tighten or refinancing windows close.
"Lenders in this space are going to be price setters rather than price takers, whereas in a lot of other private credit industries there's so much competition that private credit firms are price takers instead."
Brendan Fay — Founder and CIO of Coda Capital. After being diagnosed with rheumatoid arthritis and finding relief through medical cannabis, Fay partnered with a vertically integrated cannabis operator in Missouri to establish Coda Capital, a private credit firm dedicated to financing cannabis industry winners. His firm focuses on limited-license states where regulatory scarcity creates durable competitive advantages for operators and sustainable returns for creditors.
Full answer and detailsRead the whole answer, key facts and every other question from this episode
In short
Cannabis private credit funds target equity returns at two times leverage or less, whereas traditional private credit firms typically deploy five to ten times EBITDA while delivering only sub-10% yields.
Apex Group Editorial Team · The Fast Five: Could cannabis private credit be an overlooked opportunity? · The Single Source · answer at 2:48
Key takeaways
- This conservative leverage structure fundamentally realigns risk and return incentives in the cannabis credit space.
- The difference is not accidental—it reflects the structural realities of lending into limited-license cannabis markets.
- The competitive environment reinforces this strategy.
- This structural advantage extends beyond leverage ratios.
- Brendan Fay — Founder and CIO of Coda Capital.
Quote to remember
“Lenders in this space are going to be price setters rather than price takers, whereas in a lot of other private credit industries there's so much competition that private credit firms are price takers instead.”
— Apex Group Editorial Team
The full answer · about 1 min
Cannabis private credit funds target equity returns at two times leverage or less, whereas traditional private credit firms typically deploy five to ten times EBITDA while delivering only sub-10% yields. This conservative leverage structure fundamentally realigns risk and return incentives in the cannabis credit space.
The difference is not accidental—it reflects the structural realities of lending into limited-license cannabis markets. As Brendan Fay explains in the episode, cannabis operators in these restricted jurisdictions generate outsized profitability precisely because licenses are scarce. Deploying less leverage while targeting higher absolute returns per dollar deployed allows private credit firms to align with their borrowers' actual cash generation capacity rather than assume aggressive leverage can be serviced indefinitely.
The competitive environment reinforces this strategy. Lenders in cannabis private credit operate as price setters rather than price takers, a luxury unavailable to most traditional private credit firms drowning in capital competition. With approximately $5.4 billion in cannabis maturity obligations due in the next 24 months and a severe scarcity of available capital to refinance these loans, cannabis-focused lenders can dictate terms without racing to the bottom on pricing. Traditional private credit markets, by contrast, are saturated with capital seeking deployment, forcing firms to leverage higher just to compete on risk-adjusted returns.
This structural advantage extends beyond leverage ratios. By maintaining disciplined leverage discipline while targeting equity-like returns, cannabis private credit firms can weather volatility in both the macroeconomic environment and regulatory landscape. They avoid the trap of traditional private credit funds that have grown dependent on multiple compression to justify their outsized leverage—a trap that exposes them when markets tighten or refinancing windows close.
"Lenders in this space are going to be price setters rather than price takers, whereas in a lot of other private credit industries there's so much competition that private credit firms are price takers instead."
Brendan Fay — Founder and CIO of Coda Capital. After being diagnosed with rheumatoid arthritis and finding relief through medical cannabis, Fay partnered with a vertically integrated cannabis operator in Missouri to establish Coda Capital, a private credit firm dedicated to financing cannabis industry winners. His firm focuses on limited-license states where regulatory scarcity creates durable competitive advantages for operators and sustainable returns for creditors.